Skip to content

Search

Showing results for "Childhood interstitial lung disease "

Primary school teacher outcomes from online professional development for physical literacy: A randomised controlled trial

Primary (or elementary) school teachers are often relied upon to provide children with opportunities for physical literacy development; however, many of these teachers feel they lack the skills to effectively promote or ‘teach’ physical literacy.

The relationship between physical activity, self-regulation and cognitive school readiness in preschool children

Limited research exists on the pathways through which physical activity influences cognitive development in the early years. This study examined the direct and indirect relationships between physical activity, self-regulation, and cognitive school readiness in preschool children.

Annual Performance Reports

Find out more about the activities and highlights of ORIGINS.

New FHRI funding to support research helping kids have a healthier start to life

ORIGINS has secured $500,000 in funding from the WA Government’s Future Health Research and Innovation (FHRI) Fund.

Major milestone for Early Moves; a key sub-project of ORIGINS investigating early signs of learning difficulties in babies

Ground-breaking WA-led study, Early Moves has hit a major milestone, with 3,000 participants successfully recruited over a four-year period. 

New funding supports program to create "happier" parents

New funding from Channel 7 Telethon Trust is allowing ECU researchers to work with ORIGINS families to investigate how parents and their babies can best be supported in the first year.

Virtually More Convenient

ORIGINS is now offering telehealth appointments for the paediatric assessment at the one- and three-year timepoints

Management of patients with diffuse intrinsic pontine glioma in Australia and New Zealand: Australian and New Zealand Children's Haematology/Oncology Group position statement

The main mission of the Australian and New Zealand Children's Haematology and Oncology Group is to develop and facilitate local access to the world's leading evidence-based clinical trials for all paediatric cancers, including brain tumours, as soon as practically possible. 

Combining CRISPR-Cas9 and TCR exchange to generate a safe and efficient cord blood-derived T cell product for pediatric relapsed AML

Hematopoietic cell transplantation (HCT) is an effective treatment for pediatric patients with high-risk, refractory, or relapsed acute myeloid leukemia (AML). However, a large proportion of transplanted patients eventually die due to relapse. To improve overall survival, we propose a combined strategy based on cord blood (CB)-HCT with the application of AML-specific T cell receptor (TCR)-engineered T cell therapy derived from the same CB graft.

Interpregnancy interval and adverse birth outcomes: a population-based cohort study of twins

To investigate associations between interpregnancy intervals (IPIs) and adverse birth outcomes in twin pregnancies.